Compound Detail

CHEMBL1814602

Enter ChEMBL ID:

Free Research Context This compound will appear in recent viewed items on the research home for this browser.

CCOP(=O)(CC(CC)N=C=S)OCC

ChEMBL ↗ Properties Compare Identifier

Basic Information

ChEMBL ID	CHEMBL1814602
Phase	Preclinical
Structure Type	MOL
InChI Key	QUIABGAWVGUHOZ-UHFFFAOYSA-N

Targets

Activities

Assay Types

PK Parameters

Publications

Known Names

251.3

MW (Da)

3.13

ALogP

HBA

HBD

47.9

PSA (Å²)

0.38

QED

Ro5 Violations

Rot. Bonds

First in Class Prodrug

IC50 5 meas. best 5.12

Target	Type	Best pChEMBL	Mean pChEMBL	Best (nM)	# Data
MCF7 CHEMBL387	IC50	5.12	5.12	7600.0	1
LoVo CHEMBL614721	IC50	5.1	5.09	8000.0	2
A549 CHEMBL392	IC50	4.77	4.77	16900.0	1
T47D CHEMBL614361	IC50	4.75	4.75	17700.0	1

Top measurements by pChEMBL value

Target	Type	Rel.	Value	Units	pChEMBL	Assay	PubMed
MCF7	IC50	=	7600.0	nM	5.12	Antiproliferative activity against human MCF7 cells after 72 hrs by SRB assay	21704523
LoVo	IC50	=	8000.0	nM	5.1	Antiproliferative activity against human LoVo cells after 72 hrs by SRB assay	21704523
LoVo	IC50	=	8340.0	nM	5.08	Antiproliferative activity against doxorubicin-resistant human LoVo cells after ...	21704523
A549	IC50	=	16900.0	nM	4.77	Antiproliferative activity against human A549 cells after 72 hrs by SRB assay	21704523
T47D	IC50	=	17700.0	nM	4.75	Antiproliferative activity against human T47D cells after 72 hrs by SRB assay	21704523

PubMed	DOI	Target Context	# Activities
21704523	10.1016/j.bmcl.2011.05.113	A549	17
21704523	10.1016/j.bmcl.2011.05.113	LoVo	2
21704523	10.1016/j.bmcl.2011.05.113	T47D	1
21704523	10.1016/j.bmcl.2011.05.113	MCF7	1

Data from ChEMBL 36 via Core Engine